Nantahala Capital Management - LAVA THERAPEUTICS NV ownership

LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 19 filers reported holding LAVA THERAPEUTICS NV in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of LAVA THERAPEUTICS NV
ValueSharesWeighting
Q2 2022$953,000
-35.2%
322,980
-3.3%
0.05%
-26.2%
Q1 2022$1,470,000
-25.9%
334,164
-7.4%
0.06%
-7.1%
Q4 2021$1,984,000
-9.2%
360,808
-2.3%
0.07%
+1.4%
Q3 2021$2,186,000
-47.3%
369,290
-3.1%
0.07%
-41.5%
Q2 2021$4,148,000
-28.4%
381,2270.0%0.12%
-30.2%
Q1 2021$5,791,000381,2270.17%
Other shareholders
LAVA THERAPEUTICS NV shareholders Q2 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 610,809$2,791,0000.94%
Novo Holdings A/S 3,327,312$15,206,0000.72%
Redmile Group, LLC 2,816,196$12,870,0000.50%
Alpha Wave Global, LP 121,193$554,0000.06%
Artal Group S.A. 200,000$914,0000.04%
Cannell Capital 17,955$82,0000.02%
UBS OCONNOR LLC 75,000$343,000,0000.01%
AXA S.A. 457,342$2,090,0260.00%
TSFG, LLC 400$2,0000.00%
OSAIC HOLDINGS, INC. 48$00.00%
View complete list of LAVA THERAPEUTICS NV shareholders